Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.3%

2 terminated/withdrawn out of 156 trials

Success Rate

92.0%

+5.5% vs industry average

Late-Stage Pipeline

13%

21 trials in Phase 3/4

Results Transparency

0%

0 of 23 completed trials have results

Key Signals

52 recruiting

Enrollment Performance

Analytics

N/A
48(41.0%)
Phase 2
20(17.1%)
Phase 1
19(16.2%)
Phase 3
11(9.4%)
Phase 4
10(8.5%)
Early Phase 1
9(7.7%)
117Total
N/A(48)
Phase 2(20)
Phase 1(19)
Phase 3(11)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (156)

Showing 20 of 156 trials
NCT05965687Phase 3Completed

Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke (OPENS-3)

Role: collaborator

NCT06577792Not ApplicableActive Not Recruiting

Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY)

Role: collaborator

NCT07295366Phase 4Completed

Early Administration of PCSK9 Inhibitors After Thrombectomy for Atherosclerotic Acute Ischemic Stroke: A Randomized Controlled Trial

Role: lead

NCT07680933Phase 2Recruiting

Orelabrutinib Combined With Standard Immunochemotherapy With or Without Autologous Hematopoietic Stem Cell Transplantation (Auto-HSCT) for Newly Diagnosed Diffuse Large B-cell Lymphoma (DLBCL)

Role: lead

NCT07634861Not ApplicableRecruiting

Evaluating a Text-Prompt AI Assistant for Chest CT Scans (AI-REPORT Study)

Role: collaborator

NCT06711016Not ApplicableRecruiting

Target-directed Management of Cerebral Oxygenation in Patients After Receiving ECPR

Role: collaborator

NCT07163299Phase 1Enrolling By Invitation

Intra-arterial Selective Hypothermic Magnesium Sulfate Infusion in Combination With Endovascular Thrombectomy in Acute Ischemic Stroke

Role: collaborator

NCT07410377Early Phase 1Withdrawn

UCAR T-cell Therapy Targeting CD19/ BCMA(QT-019C) in Patients With Relapse/ Refractory Autoimmune Diseases

Role: lead

NCT05129904Active Not Recruiting

Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint (PADSTONE Study)

Role: collaborator

NCT07602439Active Not Recruiting

Early CMR in Acute MI

Role: lead

NCT05788029Not ApplicableEnrolling By Invitation

Comparing Laparoscopic and Open Pancreaticoduodenectomy for Nonpancreatic Periampullary Adenocarcinomas

Role: collaborator

NCT07332858Phase 1Recruiting

First-in-Human Expanded Cohort Study of Intrapleural Administration of TolueneSulfonamide in Patients With Malignant Pleural Effusion

Role: collaborator

NCT06241651Not ApplicableRecruiting

CSP Versus BiVP for Heart Failure Patients With RVP Upgraded to Cardiac Resynchronization Therapy

Role: collaborator

NCT07301372Phase 4Completed

Evaluation Study of Early Administration of Evolocumab After Thrombolysis in Patients With Atherosclerotic Acute Ischemic Stroke

Role: lead

NCT06304779Not ApplicableRecruiting

The Effect of Continuous Intravenous Infusion of Lidocaine on PPCs and Prognosis in Emergency Surgical Patients With IAI

Role: collaborator

NCT07546110Early Phase 1Not Yet Recruiting

An Open-Label, Single-Arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of CD20 Monoclonal Antibody Combined With NK042 Cell Injection in the Treatment of Multiple Sclerosis (MS).

Role: lead

NCT07533825Not ApplicableEnrolling By Invitation

Laparoscopic Staging for Stage III Gastric Cancer

Role: collaborator

NCT06790810Completed

Observational Study on Dynamic Changes of Blood Pressure During Post-epileptic Seizure Stage (OCBPS)

Role: collaborator

NCT07413835Not ApplicableRecruiting

Efficacy and Safety of HN2302 in Refractory Myasthenia Gravis(MG)

Role: lead

NCT07446452Phase 2Recruiting

Disitamab Vedotin Plus Bevacizumab in HER2-Low Metastatic Breast Cancer After T-DXd Failure: A Phase II Study

Role: collaborator